These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 26547011
1. Sodium Nitroprusside in Patients With Mixed Pulmonary Hypertension and Left Heart Disease: Hemodynamic Predictors of Response and Prognostic Implications. Lim HS, Zaphiriou A. J Card Fail; 2016 Feb; 22(2):117-24. PubMed ID: 26547011 [Abstract] [Full Text] [Related]
2. The effect of left ventricular assist device therapy in patients with heart failure and mixed pulmonary hypertension. Lim HS, Howell N, Ranasinghe A. Int J Artif Organs; 2017 Mar 16; 40(2):67-73. PubMed ID: 28315502 [Abstract] [Full Text] [Related]
7. Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients. Torres Macho J, Delgado Jimenez JF, Sanz Salvo J, Gonzalez Mansilla A, Sanchez Sanchez V, Gamez Diez S, Escribano Subias P, Saenz de la Calzada C. Transplant Proc; 2009 Mar 16; 41(6):2477-9. PubMed ID: 19715956 [Abstract] [Full Text] [Related]
8. Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation. Hefke T, Zittermann A, Fuchs U, Schulte-Eistrup S, Gummert JF, Schulz U. Thorac Cardiovasc Surg; 2012 Feb 16; 60(1):26-34. PubMed ID: 21432755 [Abstract] [Full Text] [Related]
9. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension. Pamboukian SV, Carere RG, Webb JG, Cook RC, D'yachkova Y, Abel JG, Ignaszewski AP. J Heart Lung Transplant; 1999 Apr 16; 18(4):367-71. PubMed ID: 10226902 [Abstract] [Full Text] [Related]
10. Sildenafil vs. sodium before nitroprusside for the pulmonary hypertension reversibility test before cardiac transplantation. Freitas AF, Bacal F, Oliveira Júnior Jde L, Fiorelli AI, Santos RH, Moreira LF, Silva CP, Mangini S, Tsutsui JM, Bocchi EA. Arq Bras Cardiol; 2012 Sep 16; 99(3):848-56. PubMed ID: 22898992 [Abstract] [Full Text] [Related]
11. Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension. Ghio S, Crimi G, Temporelli PL, Traversi E, La Rovere MT, Cannito A, Vizza D, Scelsi L, Raineri C, Guazzi M, Oltrona Visconti L. Eur J Heart Fail; 2018 Apr 16; 20(4):725-734. PubMed ID: 29148140 [Abstract] [Full Text] [Related]
15. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. Kieler-Jensen N, Lundin S, Ricksten SE. J Heart Lung Transplant; 1995 Apr 16; 14(3):436-43. PubMed ID: 7654728 [Abstract] [Full Text] [Related]
16. Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease. Nagy AI, Venkateshvaran A, Merkely B, Lund LH, Manouras A. Eur J Heart Fail; 2017 Jan 16; 19(1):88-97. PubMed ID: 27748008 [Abstract] [Full Text] [Related]
18. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. Melenovsky V, Al-Hiti H, Kazdova L, Jabor A, Syrovatka P, Malek I, Kettner J, Kautzner J. J Am Coll Cardiol; 2009 Aug 11; 54(7):595-600. PubMed ID: 19660688 [Abstract] [Full Text] [Related]
19. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient. Ibe T, Wada H, Sakakura K, Ikeda N, Yamada Y, Sugawara Y, Mitsuhashi T, Ako J, Fujita H, Momomura S. J Cardiol; 2016 Jun 11; 67(6):555-9. PubMed ID: 26299611 [Abstract] [Full Text] [Related]